Guideline Directed Medical Therapy is one of 81 small molecule programs targeting Ischemic Cardiomyopathy. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
206 competitors in Heart Failure
Guideline Directed Medical Therapy
Bayer Aspirin
Brethine
Medrol
Zemplar
Adriamycin
Savaysa
Activase
Xylocaine
Tamiflu
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details